Bafna Pharmaceuticals Ltd
Bafna Pharmaceuticals is engaged in the Business of manufacture of pharmaceutical products.
- Market Cap ₹ 302 Cr.
- Current Price ₹ 124
- High / Low ₹ 234 / 4.40
- Stock P/E
- Book Value ₹ -1.79
- Dividend Yield 0.00 %
- ROCE -5.59 %
- ROE -25.7 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Debtor days have improved from 151.40 to 51.82 days.
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -15.16% over past five years.
- Company has a low return on equity of -89.09% for last 3 years.
- Company might be capitalizing the interest cost
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Formulations
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Jun 2018 | Sep 2018 | Jun 2019 | Sep 2019 | |
---|---|---|---|---|
11.95 | 8.84 | 6.85 | 11.57 | |
13.77 | 8.66 | 9.71 | 11.95 | |
Operating Profit | -1.82 | 0.18 | -2.86 | -0.38 |
OPM % | -15.23% | 2.04% | -41.75% | -3.28% |
Other Income | 0.09 | -0.03 | 0.30 | 0.59 |
Interest | 0.83 | 0.62 | 0.13 | 0.04 |
Depreciation | 1.00 | 0.75 | 1.02 | 0.72 |
Profit before tax | -3.56 | -1.22 | -3.71 | -0.55 |
Tax % | 1.12% | -4.10% | 42.59% | -7.27% |
Net Profit | -3.52 | -1.28 | -2.13 | -0.59 |
EPS in Rs | -1.49 | -0.54 | -0.90 | -2.49 |
Notes | Notes | Notes | Notes |
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|---|---|
129 | 175 | 185 | 97 | 85 | 65 | 46 | 44 | 42 | |
110 | 153 | 162 | 117 | 85 | 71 | 81 | 57 | 41 | |
Operating Profit | 19 | 22 | 23 | -20 | 1 | -6 | -35 | -13 | 1 |
OPM % | 15% | 13% | 12% | -21% | 1% | -9% | -77% | -30% | 3% |
Other Income | 1 | 3 | 2 | 46 | 2 | 1 | 31 | 1 | -22 |
Interest | 8 | 12 | 13 | 13 | 13 | 11 | 7 | 2 | 0 |
Depreciation | 6 | 8 | 9 | 6 | 5 | 4 | 4 | 3 | 3 |
Profit before tax | 5 | 5 | 2 | 6 | -15 | -20 | -15 | -17 | -24 |
Tax % | 64% | 27% | 42% | -2% | 1% | 4% | -15% | -6% | 0% |
Net Profit | 2 | 4 | 1 | 6 | -14 | -19 | -17 | -19 | -25 |
EPS in Rs | 1.00 | 2.12 | 0.75 | 3.31 | -7.52 | -10.23 | -7.08 | -7.98 | -104.54 |
Dividend Payout % | 0% | 28% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | -15% |
3 Years: | -13% |
TTM: | -3% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 14% |
3 Years: | 24% |
TTM: | 90% |
Stock Price CAGR | |
---|---|
10 Years: | 11% |
5 Years: | 35% |
3 Years: | 66% |
1 Year: | 3393% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | -53% |
3 Years: | -89% |
Last Year: | -26% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|---|---|
18 | 19 | 19 | 19 | 19 | 19 | 24 | 24 | 2 | |
Reserves | 40 | 46 | 50 | 53 | 39 | 20 | 14 | -5 | -7 |
Borrowings | 85 | 100 | 108 | 69 | 80 | 82 | 47 | 46 | 3 |
76 | 96 | 59 | 59 | 54 | 57 | 54 | 54 | 73 | |
Total Liabilities | 219 | 261 | 236 | 200 | 193 | 178 | 138 | 119 | 71 |
76 | 73 | 69 | 55 | 53 | 49 | 45 | 37 | 35 | |
CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments | 0 | 0 | 0 | 17 | 17 | 17 | 0 | 0 | 0 |
143 | 188 | 167 | 128 | 123 | 113 | 93 | 82 | 36 | |
Total Assets | 219 | 261 | 236 | 200 | 193 | 178 | 138 | 119 | 71 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|---|---|
29 | 37 | 2 | 11 | 1 | -1 | -7 | -2 | -34 | |
-38 | -6 | -7 | 60 | -0 | -5 | 38 | 15 | 33 | |
-1 | -12 | -13 | -71 | -1 | 6 | -31 | -14 | 7 | |
Net Cash Flow | -9 | 19 | -18 | -0 | -0 | -0 | 0 | -0 | 6 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|---|---|
ROCE % | 11% | 9% | -12% | -2% | -7% | -37% | -22% | -6% | |
Debtor Days | 237 | 191 | 193 | 335 | 292 | 303 | 195 | 208 | 52 |
Inventory Turnover | 5.67 | 5.31 | 3.85 | 4.22 | 3.26 | 2.95 | 3.04 | 2.19 |
Documents
Add documentRecent announcements
- Outcome Of The Board Meeting Held On 12Th February 2021 12 Feb
- Outcome Of Board Meeting 12 Feb
- Board Meeting Intimation for To Inter Alia Consider And Adopt Un-Audited Financial Results For The Quarter And Nine Months Ended 31St December 2020 And Any Other Business With The Permission Of The Chair. 2 Feb
- Sub.:- Disclosure Under Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Details Of Related Party Transactions 20 Jan
- Shareholding for the Period Ended December 31, 2020 13 Jan
View all
Annual reports
- Financial Year 2020 from bse
- Financial Year 2019 from bse
- Financial Year 2018 from bse
- Financial Year 2017 from bse
- Financial Year 2016 from bse
- Financial Year 2015 from bse
- Financial Year 2014 from bse
- Financial Year 2013 from bse
- Financial Year 2013 from nse
- Financial Year 2011 from bse
- Financial Year 2010 from bse